Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO Medical Dialogues Bureau17 Jan 2020 12:45 PM ISTSan Francisco: Eli Lilly and Co aim to announce roughly one $1 billion (765 million pounds) to $5 billion (3.8 billion pounds) deal every quarter in...
Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list Medical Dialogues Bureau29 Nov 2019 9:15 AM ISTSeventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab,...
Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus Medical Dialogues Bureau23 Sept 2019 2:16 PM ISTNovo Nordisk did not disclose what it plans to charge for the new oral treatment, called Rybelsus, but said it would be "competitively priced" with...
Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 9:30 AM ISTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Lupin unveils generic version of Prozac tablets in US Medical Dialogues Bureau24 Aug 2019 9:45 AM ISTFluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
Roche names Eli Lilly executive Levi Garraway as chief medical officer Medical Dialogues Bureau20 Aug 2019 9:00 AM ISTLevi Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel target...
AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year Medical Dialogues Bureau18 Aug 2019 9:36 AM ISTA four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder Medical Dialogues Bureau17 Aug 2019 9:45 AM ISTThe company has received approval for Fluoxetine Tablets from the US Food and Drug Administration(USFDA) to market its product which is a generic...
Eli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent lawsuit Medical Dialogues Bureau13 Aug 2019 9:15 AM ISTThe ruling came in the appeals of U.S. District Court decisions in the cases of Eli Lilly and Company v. Dr Reddy's Laboratories and Eli Lilly and...
Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma Medical Dialogues Bureau14 May 2019 9:47 AM ISTThe USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation...
Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions Farhat Nasim12 May 2019 9:30 AM ISTWeekly U.S. prescription data from IQVIA, an analytics provider to the life sciences industry, showed that Lilly's therapy Emgality claimed the...
Washington: Drugmakers will have to reveal medicine prices in TV ads Medical Dialogues Bureau10 May 2019 9:10 AM ISTHealth and Human Services Secretary Alex Azar said the Trump administration has finalized regulations that will require drug companies to disclose...
